| FDMT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the FDMT shares outstanding history going back to 12/11/2020:
Also see: FDMT Market Cap History FDMT YTD Return |
FDMT Shares Outstanding History — 4D Molecular Therapeutics Share Count Over Time
As of 5/4/2026 4D Molecular Therapeutics has 16.94 million FDMT shares outstanding. Investors often track the FDMT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows FDMT share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 12/11/2020.
| FDMT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
FDMT Historical Shares Outstanding: -4.41% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| FDMT Stock Price Chart |
| About 4D Molecular Therapeutics Inc |
| 4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on treating ophthalmology and pulmonology diseases. It has five product candidates in clinical trials: 4D-150 for wet age-related macular degeneration and diabetic macular edema, 4D-710 for cystic fibrosis lung disease, 4D-310 for Fabry disease cardiomyopathy, 4D-125 for X-linked retinitis pigmentosa, and 4D-110 for choroideremia. Additionally, it has two preclinical candidates: 4D-175 for geographic atrophy and 4D-725 for alpha-1 antitrypsin deficiency lung disease. We show 21 historical shares outstanding datapoints in our coverage of FDMT's shares outstanding history. Understanding the changing numbers of FDMT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like FDMT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching FDMT by allowing them to research FDMT shares outstanding history as well as any other stock in our coverage universe. |
| FDMT Current Stock Quote |
Quotes delayed 20 minutes  Free FDMT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| FDMT Share Performance |
| Shares Outstanding Peers |
| 4D Molecular Therapeutics (FDMT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
FEED Shares Outstanding History FEMY Shares Outstanding History FGEN Shares Outstanding History FHTX Shares Outstanding History FIXX Shares Outstanding History FLDM Shares Outstanding History FLGT Shares Outstanding History FLKS Shares Outstanding History FLXN Shares Outstanding History FMI Shares Outstanding History More Healthcare companies » |
FDMT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
